Veracyte, Inc. (VCYT)

NASDAQ: VCYT · Real-Time Price · USD

32.78

-0.59 (-1.77%)

At close: Mar 10, 2026, 4:00 PM EDT

33.43

+0.65 (1.98%)

After-hours: Mar 10, 2026, 6:50 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Diagnostic Products and Biopharmaceutical Services	517.15M	445.76M	361.05M	296.54M	219.51M
Diagnostic Products and Biopharmaceutical Services Growth	16.01%	23.46%	21.76%	35.09%	86.85%
Total	517.15M	445.76M	361.05M	296.54M	219.51M
Total Growth	16.01%	23.46%	21.76%	35.09%	86.85%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	496.60M	423.54M	334.53M	262.92M	200.98M
United States Growth	17.25%	26.61%	27.23%	30.82%	83.35%
International	20.55M	22.23M	26.53M	33.61M	18.53M
International Growth	-7.56%	-16.21%	-21.08%	81.38%	135.51%
Total	517.15M	445.76M	361.05M	296.54M	219.51M
Total Growth	16.01%	23.46%	21.76%	35.09%	86.85%

Source: S&P Global Market Intelligence.